Physician profile
Jennifer J Everett
NPI 1609117035
$875.75
in general payments reported to CMS, 2019-2025
6 companies · $59.89 in 2025
The $59.89 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $346 · 2021: $210 · 2022: $30.54 · 2024: $16.50 · 2025: $59.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $701.49 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $90.43 | 2022-2025 | Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $29.13 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $26.61 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $16.50 | 2024 | Xdemvy |
| Shire North American Group INC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.